Osteopontin expression in mammary gland development and tumorigenesis

Cell Growth and Differentiation

Volumn 8, Issue 10, 1997, Pages 1061-1069

  Rittling, Susan R ^a   Novick, Kristine E ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN; VIRUS VECTOR;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST DEVELOPMENT; BREAST TUMOR; CARCINOGENESIS; CELL ADHESION; FEMALE; LACTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN SYNTHESIS REGULATION; TRANSGENIC MOUSE;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL ADHESION; FEMALE; GENE EXPRESSION; GENES, MYC; GENES, RAS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LACTATION; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; OSTEOPONTIN; PREGNANCY; PREGNANCY, ANIMAL; RNA, MESSENGER; SIALOGLYCOPROTEINS; TIME FACTORS; TRANSFECTION;

ANIMALIA; MAMMARY TUMOR VIRUS; MOUSE MAMMARY TUMOR VIRUS; MUS MUSCULUS; TUMOR VIRUS;

EID: 0030840409     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Brown, L. F., Berse, B., Van de Water, L., Papadopoulos-Sergiou, A., Perruzzi, C. A., Manseau, E. J., Dvorak, H. F., and Senger, D. R. Expression and distribution of osteopontin in human tissues; widespread association with luminal epithelial surfaces. Mol. Biol. Cell, 3: 1169-1180, 1992.
2. Denhardt, D. T., and Quo, X. Osteopontin: a protein with diverse functions. FASEB J., 7: 1475-1482, 1993.
3. Butler, W. T., Ridall, A. L., and McKee, M. D. Osteopontin. In: J. P. Bilezkian, L. G. Raisz, and G. A. Rodan (eds.), Principles of Bone Biology, pp. 167-181. San Diego, CA: Academic Press, 1996.
4. Giachelli, C. M., Schwartz, S. M., and Liaw, L. Molecular and cellular biology of osteopontin: potential role in cardiovascular disease. Trends Cardiovasc. Med., 5: 88-95, 1995.
5. Murry, C. E., Giachelli, C. M., Schwartz, S. M., and Vracko, R. Macrophages express osteopontin during repair of myocardial necrosis. Am. J. Pathol., 145: 1450-1462, 1994.
6. Nau, G. J., Guilfoile, P., Chupp, G. L., Berman, J. S., Kim, S. J., Kornfield, H., and Young, R. A. A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. Proc. Natl. Acad. Sci. USA, 94: 6414-6419, 1997.
7. Patarca, R., Saavedra, R. A., and Cantor, H. Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/osteopontin gene. Crit. Rev. Immunol., 13: 225-246, 1993.
8. Weber, G. F., and Cantor, H. The immunology of Eta-1/osteopontin. Cytokine Growth Factor Res., 7: 241-248, 1996.
9. 3 in smooth muscle migration to osteopontin in vitro. J. Clin. Invest., 95: 713-724, 1995.
10. Butler, W. T. The nature and significance of osteopontin. Connect. Tissue Res., 23: 123-136, 1989.
11. Sörensen, E. S., Hojrup, P., and Petersen, T. E. Post-translational modification of bovine osteopontin: identification of twenty-eight phosphorylation and three O-glycosylation sites. Protein Sci., 4: 2040-2049, 1995.
12. Bautista, D. S., Xuan, J. W., Hota, C., Chambers, A. F., and Harris, J. F. Inhibition of Arg-Gly-Asp (RGD)-mediated cell adhesion to osteopontin by a monoclonal antibody against osteopontin. J. Biol. Chem., 269: 23280-23285, 1994.
13. 3 potentiate bone resorption. J. Biol. Chem., 268: 9901-9907, 1993.
14. 3 integrin, osteopontin, and thrombin. Am. J. Pathol., 149: 293-305, 1996.
15. Senger, D. R., and Perruzzi, C. A. Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin. Biochim. Biophys. Acta, 1314: 13-24, 1996.
16. 3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity. Endocrinology, 136: 2984-2992, 1995.
17. v subunit. Endocrinology, 137: 2432-2440, 1996.
18. i in rat osteoclasts and mouse-derived osteoclast-like cells. Am J. Physiol., 1266: C376-C381, 1994.
19. 3 integrin stimulates immediate cell signals in osteoclasts. J. Biol. Chem., 266: 20369-20374, 1991.
20. Hwang, S. M., Lopez, C. A., Heck, D. E., Gardner, C. R., Laskin, D. L., Laskin, J. D., and Denhardt, D. T. Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J. Biol. Chem., 269: 711-715, 1994.
21. Rollo, E. E., Laskin, D. L., and Denhardt, D. T. Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW 264.7 macrophages. J. Leukocyte Biol., 60: 397-404, 1996.
22. Shiraga, H., Min, W., VanDusen, W. J., Clayman, M. D., Miner, D., Terrell, C. H., Sherbotie, J. R., Foreman, J. W., Przysiecki, C., Neilson, E. G., and Hoyer, J. R. Inhibition of calcium oxalate crystal growth in vitro by uropontin, a new member of the aspartic acid-rich protein superfamily. Proc. Natl. Acad. Sci. USA, 89: 426-430, 1992.
23. Bosky, A. L., Maresca, M., Ullrich, W., Doty, S. B., Butler, W. T., and Prince, C. W. Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin gel. Bone Miner., 22: 147-159, 1993.
24. Hunter, G. K., Hauschka, P. V., Poole, A. R., Rosenberg, L. C., and Goldberg, H. A. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem. J., 317: 59-64, 1996.
25. Senger, D. R., Asch, B. B., Smith, B. D., Perruzzi, C. A., and Dvorak, H. F. A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells. Nature (Lond.), 302: 714-715, 1983.
26. Senger, D. R., Perruzzi, C. A., and Papadopoulos, A. Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation. Anticancer Res., 9: 1291-1300, 1989.
27. Smith, J. H., and Denhardt, D. T. Molecular cloning of a tumor promoter-inducible mRNA found in JB6 mouse epidermal cells: induction is stable at high, but not at low, cell densities. J. Cell. Biochem., 34: 13-22, 1987.
28. Craig, A. M., Smith, J. H., and Denhardt, D. T. Osteopontin, a transformation-associated cell adhesion phosphoprotein, is induced by 12-O-tetradecanoylphorbol-13-acetate in mouse epidermis. J. Biol. Chem., 264: 9682-9689, 1989.
29. Craig, A. M., Bowden, G. T., Chambers, A. F., Spearman, M. A., Greenberg, A. H., Wright, J. A., McLeod, M., and Denhardt, D. T. Secreted phosphoprotein mRNA is induced during multistage carcinogenesis in skin and correlates with the metastatic potential of murine fibroblasts. Int. J. Cancer, 46: 133-137, 1990.
30. Gardner, H. A. R., Berse, B., and Senger, D. R. Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts. Oncogene, 9: 2321-2326, 1994.
31. Behrend, E. I., Craig, A. M., Wilson, S. M., Denhardt, D. T., and Chambers, A. F. Reduced malignancy of ras-transformed NIH3T3 cells expressing antisense osteopontin RNA. Cancer Res., 54: 832-837, 1994.
32. Feng, B., Rollo, E. E., and Denhardt, D. T. Osteopontin (OPN) may facilitate metastasis by protecting cells from macrophage NO-mediated cytotoxicity: evidence from cell lines down-regulated for OPN expression by a targeted ribozyme. Clin. Exp. Metastasis, 13: 453-462, 1995.
33. Su, L., Mukherjee, A. B., and Mukherjee, B. B. Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells. Oncogene, 10: 2163-2169, 1995.
34. Guo, X., Zhang, Y. P., Mitchell, D. A., Denhardt, D. T., and Chambers, A. F. Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell. Mol. Cell. Biol., 15: 476-487, 1995.
35. Oates, A. J., Barraclough, R., and Rudland, P. S. Enhanced expression of the osteopontin gene in metastatic rat mammary epithelial-derived cell lines. Oncogene, 13: 97-104, 1996.
36. Chen, H., Ke, Y., Dates, A. J., Barraclough, R., and Rudland, P. S. Isolation of and effector for metastasis-inducing DNAs from a human metastatic carcinoma cell line. Oncogene, 14: 1581-1588, 1997.
37. Senger, D. R., Perruzzi, C. A., Papadopoulos, A., and Tenen, D. G. Purification of a human milk protein closely similar to tumor-secreted phosphoproteins and osteopontin. Biochim. Biophys. Acta, 966: 43-48, 1989.
38. Brown, L. F., Papadopoulos-Sergiou, A., Berse, B., Manseau, E. J., Tognazzi, K., Perruzzi, C. A., Dvorak, H. F., and Senger, D. R. Osteopontin expression and distribution in human carcinomas. Am. J. Pathol., 145: 610-623, 1994.
39. Jerry, D. J., Butel, J. S., Donehower, L A., Paulson, E. J., Cochran, C., Wiseman, R. W., and Medina, D. Infrequent p53 mutations in 7,12-dimethylbenz(a)anthracene-induced mammary tumors in BALB/c and p53 hemizygous mice. Mol. Carcinog., 9: 175-183, 1994.
40. Sinn, E., Muller, W., Pattengale, P., Tepler, I., Wallace, R., and Leder, P. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell, 49: 465-475, 1987.
41. Pattengale, P. K., Stewart, T. A., Leder, A., Sinn, E., Muller, W., Tepler, I., Schmidt, E., and Leder, P. Animal models of human disease: pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes. Am. J. Pathol., 135: 39-61, 1989.
42. Shanmugam, V., Chackalaparampil, I., Kundu, G., Mukherjee, A. B., and Mukherjee, B. B. Altered sialylation of osteopontin prevents its receptor-mediated binding on the surface of oncogenically transformed tsB77 cells. Biochemistry, 36: 5729-5738, 1997.
43. Lee, C. S., and Oka, T. A pregnancy-specific mammary factor involved in the repression of the mouse β-casein gene transcription by progesterone. J. Biol. Chem., 257: 5797-5801, 1992.
44. Lee, C. S., and Oka, T. Progesterone regulation of a pregnancy-specific transcriptional represser to β-casein gene promoter in mouse mammary gland. Endocrinology, 131: 2257-2262, 1992.
45. Robinson, G. W., McKnight, R. A., Smith, G. H., and Henninghausen, L. Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development (Camb.), 121: 2079-2090, 1995.
46. Ogra, P. L., Losonsky, G. A., and Fishaut, M. Colostrum-derived immunity and maternal-neonatal interaction. Ann. NY Acad. Sci., 409: 82-95, 1983.
47. Lampe, M. A., Patarca, R., Iregui, M. V., and Cantor, H. Polyclonal B-cell activation by the Eta-1 cytokine and the development of autoimmune disease. J. Immunol., 147: 2902-2906, 1991.
48. Lund, L. R., Romer, J., Thomasset, N., Solberg, H., Pyke, C., Bissell, M. J., Dano, K., and Werb, Z. Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development (Camb.), 122: 181-193, 1996.
49. Li, F., Strange, R., Friis, R. R., Djonov, V., Altermatt, H-J., Saurer, S., Niemann, H., and Andres, A. C. Expression of stromelysin-1 and TIMP-1 in the involuting mammary gland and in early invasive tumors of the mouse. Int. J. Cancer, 59: 560-568, 1994.
50. Bautista, D. S., Denstedt, J., Chambers, A. F., and Harris, J. F. Low molecular weight variants of osteopontin generated by serine proteases in urine of patients with kidney stones. J. Cell. Biochem., 61: 402-409, 1996.
51. Janssen, P. J., Brinkmann, A. O., Boersma, W. J., and Van Der Kwast, T. H. Immunohistochemical detection of the androgen receptor with monoclonal antibody F39.4 in routinely processed, paraffin-embedded human tissues after microwave pretreatment. J. Histochem. Cytochem., 42: 1169-1175, 1994.
52. Miyazaki, Y., Setoguchi, S., Yoshida, S., Higuchi, Y., Akizuki, S., and Yamamoto, S. The mouse osteopontin gene: expression in monocytic lineages and complete nucleotide sequence. J. Biol. Chem., 265: 14432-14438, 1990.
53. Lopez, C. A., Hoyer, J. R., Wilson, P. D., Waterhouse, P., and Denhardt, D. T. Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli. Lab. Invest., 69: 355-363, 1993.
54. Minty, A. J., Alonso, S., Guenet, J-L., and Buckingham, M. E. Number and organization of actin-related sequences in the mouse genome. J. Mol. Biol., 167: 77-101, 1983.
55. Gupta, P., Rosen, J. M., D'Eustachio, P., and Ruddle, F. R. Localization of the casein gene family to a single mouse chromosome. J. Cell. Biol., 93: 199-204, 1982.
56. Liaw, L., Almeida, M., Hart, C. E., Schwartz, S. M., and Giachelli, C. M. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ. Res., 74: 214-224, 1994.